Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Blind, Placebo-Controlled Multicentre Clinical Study for Efficacy and Safety Assessment of the Drug RADAMIN®VIRO for COVID-19 Postexposure Prophylaxis

NCT05722691 is registered in ClinicalTrials.gov with Promomed, LLC as lead sponsor.

NCT NCT05722691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05722691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Blind, Placebo-Controlled Multicentre Clinical Study for Efficacy and Safety Assessment of the Drug RADAMIN®VIRO for COVID-19 Postexposure Prophylaxis
Lead sponsor
Promomed, LLC
Phase
Phase 3
Overall status
Completed
Start date
June 9, 2022
Completion date
January 17, 2023
Enrollment
800 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19